Cue Biopharma, Inc.
CUE
$30.50
$0.501.67%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -153.07M | -5.18M | 1.59M | -7.45M | -8.48M |
| Total Depreciation and Amortization | 36.00K | 566.00K | 3.20M | -1.40M | 99.00K |
| Total Amortization of Deferred Charges | -- | -- | 9.00K | 10.00K | 9.00K |
| Total Other Non-Cash Items | 107.40M | 401.00K | -1.40M | 3.43M | 1.99M |
| Change in Net Operating Assets | 16.63M | -6.73M | -4.47M | -3.62M | 2.97M |
| Cash from Operations | -29.00M | -10.94M | -1.08M | -9.02M | -3.42M |
| Capital Expenditure | 0.00 | -121.00K | 0.00 | 0.00 | -27.00K |
| Sale of Property, Plant, and Equipment | -- | -- | 20.00K | 20.00K | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | 7.00M | -6.79M | -- |
| Cash from Investing | 0.00 | -121.00K | 7.02M | -6.77M | -27.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -1.50M | -1.00M | -1.00M |
| Issuance of Common Stock | 2.47M | 306.00K | 10.99M | 1.00M | 752.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 27.55M | -- | -- | -- | 18.05M |
| Cash from Financing | 30.02M | 306.00K | 9.49M | 1.00K | 17.80M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1.01M | -10.76M | 15.44M | -15.79M | 14.36M |